Clinical Trials Directory

Trials / Completed

CompletedNCT02093949

Substrate Ablation Guided by High Density Mapping in Atrial Fibrillation

Substrate Ablation Guided by Automatic High Density Mapping for the Treatment of Atrial Fibrillation

Status
Completed
Phase
Study type
Observational
Enrollment
152 (actual)
Sponsor
Hospital St. Joseph, Marseille, France · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

To evaluate a new AF Substrate mapping method based on automatic high density CFAE detection with a multipolar catheter (Pentaray) and the " SCI 30-40 " setting of CARTO CFAE algorithm.

Detailed description

This study is observational : This substrate ablation method is performed routinely in the centers involved in the study so, patients were not assigned by the investigators to undergo a specific procedure because of the study, in all cases patient would have beneficiate from this substrate mapping ablation method. We assessed procedural and follow up outcomes of this subatrate ablation group and compared them with an historical control group undergoing conventional ablation.

Conditions

Interventions

TypeNameDescription
PROCEDURERoutine substrate ablation without pulmonary vein Isolation
PROCEDURERoutine conventional ablation with pulmonary vein Isolation

Timeline

Start date
2013-09-01
Primary completion
2014-12-01
Completion
2016-08-01
First posted
2014-03-21
Last updated
2017-11-06
Results posted
2017-05-03

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02093949. Inclusion in this directory is not an endorsement.